Vaxeal, in partnership with leading international research institutes, has developed fixed combinations of immunotherapy-based cancer treatments that overcome the immuno-suppressive environment surrounding cancer cells and target the specific tumors.
Vaxeal Holding SA
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.vaxeal.net
Founded2009
Disease Focus
Development Stage
STOCK CODENon Listed
AddressAvenue Paul Ceresole 24 1800VeveySwitzerland
Avenue Paul Ceresole 24 1800
Vevey
Switzerland
Contact Number+41 21 977 3000
+41 21 977 3000
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/vaxeal-holding-sa” connections=”true” suffix=””]